X. Xu

A case of tumor‐to‐tumor metastasis of cutaneous malignant melanoma

D. Elder, D. Fraker, V. Livolsi, 2020, Journal of cutaneous pathology.

Lymphatic vessel density is significantly increased in melanoma

D. Elder, G. Acs, X. Xu, 2004, Journal of cutaneous pathology.

Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine‐needle aspiration specimens

T. Sun, Prabodh K. Gupta, Xiaowei Xu, 2001, Cancer.

Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients

F. Bischoff, J. Mayer, M. Maurer, 2015, Clinical and Translational Oncology.

Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma.

X. Xu, S. Roberts, P. Zhang, 2009, Archives of pathology & laboratory medicine.

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.

P. Gimotty, L. Schuchter, R. Amaravadi, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.

L. Li, Q. Huang, X. Xu, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.